a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
Active, not recruiting · NCT06166836 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors | Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-02 | NCT06166836 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InventisBio Co., Ltd | 16 |
| InxMed (Shanghai) Co., Ltd. | 10 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Affiliated Hospital of Bengbu Medical College | Bengbu | China | 1 |
| First Affiliated Hospital of Gannan Medical University | Ganzhou | China | 5 |
| Fujian Cancer Hospital | Fuzhou | China | 37 |
| General Hospital Of Eastern Theater Command | Nanjing | China | 2 |
| Henan Cancer Hospital | Zhengzhou | China | 60 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Renmin Hospital of Wuhan University | Wuhan | China | 18 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 61 |
| Xuzhou Central Hospital | Xuzhou | China | 16 |
| Zhejiang Cancer Hospital | Hangzhou | China | 34 |